AMOYTOP(SH:688278) Xin Lang Cai Jing·2025-08-08 04:37Core Insights - The report highlights the significant role of CFOs in listed companies, with the total compensation for A-share CFOs reaching 4.27 billion yuan in 2024 [1] - The average annual salary for CFOs in the biopharmaceutical sector is reported to be 1.0042 million yuan [1] Group 1: CFO Compensation - The top five highest-paid CFOs in the biopharmaceutical sector are: 1. Zhong Jianjun from Kanghong Pharmaceutical - 3 million yuan 2. Xu Baohong from Junshi Biosciences - 2.0602 million yuan 3. Ma Jie from Shenzhou Cell - 1.4297 million yuan 4. Yang Yiling from Tebao Bio - 1 million yuan 5. Ni Liangping from Aopumai - 1 million yuan [1] - The distribution of CFO salaries shows that 13% earn below 500,000 yuan, 46% earn between 500,000 and 1 million yuan, 33% earn between 1 million and 2 million yuan, and 8% earn above 2 million yuan [1] Group 2: CFO Demographics - The age distribution of CFOs indicates that those aged 40-50 constitute 54%, while those over 50 account for 38%, and those under 40 make up 8% [1] - In terms of educational background, 8% of CFOs hold a diploma, 50% have a bachelor's degree, and 42% possess a master's degree [1] Group 3: Salary Changes - Among CFOs with over two years of tenure, Xu Baohong from Junshi Biosciences experienced the largest salary decrease, with a year-on-year decline of 24.66% [1] - Liu Liwen from Zhixiang Jintai saw the highest salary increase, with a year-on-year rise of 35.91% [1]